The Mark Foundation for Cancer Research
Aspire I Award
Applications by invitation or via RFP; no open deadline stated
Last verified:
Details
| Funder | The Mark Foundation for Cancer Research |
| Budget | Up to $250,000 (up to $500,000 for clinical studies) |
| Duration | Up to 12 months (up to 24 months for clinical studies) |
| Consortium | No |
| Application | Single stage; by invitation or RFP |
| Frequency | Continuous |
Eligibility & scope
Supports high-risk, high-reward feasibility and proof-of-concept cancer research worldwide. Covers basic research, therapeutic discovery, innovative technologies, and early-stage clinical trials. PIs must be independent researchers at their institutions. Applications by invitation or focused RFP only. Indirect costs capped at 10% of direct costs. Revenue sharing terms apply.
More from The Mark Foundation for Cancer Research
Drug Discovery Partnership Awards
Emerging Leader Awards
Endeavor Awards
Momentum Fellowships and Postdoctoral Fellowships
The Mark Foundation Centers
Does this grant match your research?
Sign up free to get a personalised match score and weekly alerts for grants like this.
Get started free